Home › Funds › Octagon Capital Advisors LP › UNCY

Octagon Capital Advisors LP position in UNCY

UNICYCIVE THERAPEUTICS INC · Health Care

Octagon Capital Advisors LP reported holding 275,000 shares of UNCY (UNICYCIVE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.17% of its reported portfolio and ranking #25 among its reported holdings. Octagon Capital Advisors LP has disclosed UNCY holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)275.00K sh
Reported value held$1.29M
Portfolio Weight0.17%
First reportedQ3 2024
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's UNCY position evolved

Octagon Capital Advisors LP first disclosed a stake in UNCY in Q3 2024 at 8,559,000 shares (US$3.5M). The position peaked in Q4 2024 at 10,000,000 shares, worth US$7.9M. Across 9 filings, Octagon Capital Advisors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 275,000 shares valued at US$1.3M — a reduction of -725,000 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2025 (shares fell 9% over the following quarter), a 72% trim in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 8.56M $3.49M New
Q4 2024 10.00M $7.94M Add
Q1 2025 10.00M $5.75M Hold
Q2 2025 1.00M $4.77M Reduce
Q3 2025 1.00M $4.36M Hold
Q4 2025 1.00M $5.77M Hold
Q1 2026 1.00M $6.58M Hold
Q2 2026 1.00M $4.69M Hold
Q3 2026 275.00K $1.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UNCY and 13F data

UNCY (UNICYCIVE THERAPEUTICS INC) is a Health Care company. 63 other funds we track also report a position in UNCY — the largest reported positions include Dauntless Investment Group, LLC (US$1.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UNCY

All UNCY fund holders →

FAQ

How long has Octagon Capital Advisors LP held UNCY?

Octagon Capital Advisors LP has disclosed UNCY holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Octagon Capital Advisors LP's current position in UNCY?

As of Q3 2026, Octagon Capital Advisors LP holds 275.00K shares of UNCY (UNICYCIVE THERAPEUTICS INC), valued at $1.29M, representing 0.17% of its reported portfolio and ranking #25.

Has Octagon Capital Advisors LP been buying or selling UNCY?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in UNCY. The position peaked in Q4 2024 at 10.00M shares.

Which other funds hold UNCY?

Other major institutional holders of UNCY include Dauntless Investment Group, LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.